BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16485881)

  • 1. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
    Jorizzo J; Weiss J; Vamvakias G
    J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp.
    Gupta AK; Weiss JS; Jorizzo JL
    Skin Therapy Lett; 2001 Jun; 6(9):1-4. PubMed ID: 11550079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment.
    Jury CS; Ramraka-Jones VS; Gudi V; Herd RM
    Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
    Weiss J; Menter A; Hevia O; Jones T; Ling M; Rist T; Roberts J; Shavin JS; Sklar J; Webster G; Connolly M; Furst K; Levy S
    Cutis; 2002 Aug; 70(2 Suppl):22-9. PubMed ID: 12353677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.
    Jorizzo J; Stewart D; Bucko A; Davis SA; Espy P; Hino P; Rodriguez D; Savin R; Stough D; Furst K; Connolly M; Levy S
    Cutis; 2002 Dec; 70(6):335-9. PubMed ID: 12502122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?
    Jorizzo J
    J Drugs Dermatol; 2004; 3(1):21-6. PubMed ID: 14964743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis.
    Hoover WD; Jorizzo JL; Clark AR; Feldman SR; Holbrook J; Huang KE
    Cutis; 2014 Nov; 94(5):255-9. PubMed ID: 25474455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
    Loven K; Stein L; Furst K; Levy S
    Clin Ther; 2002 Jun; 24(6):990-1000. PubMed ID: 12117087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses.
    Menter A; Vamvakias G; Jorizzo J
    Cutis; 2008 Jun; 81(6):509-16. PubMed ID: 18666394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
    Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorouracil cream 0.5% for actinic keratoses on multiple body sites: an 18-month open-label study.
    Stough D; Bucko AD; Vamvakias G; Rafal ES; Davis SA
    Cutis; 2010 May; 85(5):267-73. PubMed ID: 20540418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation.
    Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):30-6. PubMed ID: 12353678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short incubation PDT versus 5-FU in treating actinic keratoses.
    Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
    J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.